Sheep-associated malignant catarrhal fever virus: prospects for vaccine development (Q36383828)

13 August 2017

1 reference

title

Sheep-associated malignant catarrhal fever virus: prospects for vaccine development (English)

1 reference

13 August 2017

Hong Li

1

1 reference

13 August 2017

Naomi S Taus

series ordinal

2

1 reference

13 August 2017

J Lindsay Oaks

series ordinal

3

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

133-141

1 reference

Mural folliculitis and alopecia caused by infection with goat-associated malignant catarrhal fever virus in two sika deer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Caprine herpesvirus-2-associated malignant catarrhal fever in white-tailed deer (Odocoileus virginianus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Blue wildebeest and the aetiological agent of bovine malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Epizootic malignant catarrhal fever in three bison herds: differences from cattle and association with ovine herpesvirus-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

An outbreak of sheep-associated malignant catarrhal fever in bison (Bison bison) after exposure to sheep at a public auction sale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Malignant catarrhal fever in a bison (Bison bison) feedlot, 1993-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

A simpler, more sensitive competitive inhibition enzyme-linked immunosorbent assay for detection of antibody to malignant catarrhal fever viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

PCR detection of the sheep-associated agent of malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Levels of ovine herpesvirus 2 DNA in nasal secretions and blood of sheep: implications for transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Shedding of ovine herpesvirus 2 in sheep nasal secretions: the predominant mode for transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Experimental infection of sheep with ovine herpesvirus 2 via aerosolization of nasal secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Analysis of the pathogenetic basis for shedding and transmission of ovine gamma herpesvirus 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Transmission and virological studies of a malignant catarrhal fever syndrome in the Indonesian swamp buffalo (Bubalus bubalis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Production of malignant catarrhal fever virus-free sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Predominance of BoCD8-positive T lymphocytes in vascular lesions in a 1-year-old cow with concurrent malignant catarrhal fever and bovine viral diarrhea virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Phenotyping of lymphocyte subsets in the vascular and epithelial lesions of a cow with malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Surface marker analysis of the vascular and epithelia lesions in cattle with sheep-associated malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

The vascular lesions of a cow and bison with sheep-associated malignant catarrhal fever contain ovine herpesvirus 2-infected CD8(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Phenotypic analysis of lymphoblastoid cell lines derived from cattle and deer affected with “sheep-associated” malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the gamma-herpesvirus agents of malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Phenotype, growth regulation and cytokine transcription in Ovine Herpesvirus-2 (OHV-2)-infected bovine T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

The detection of Alcelaphine herpesvirus-1 DNA by in situ hybridization of tissues from rabbits affected with malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Characterisation of the lymphoproliferation in rabbits experimentally affected with malignant catarrhal fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Transmission of malignant catarrhal fever to rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Immune evasion by gamma-herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Effective vaccination against long-term gammaherpesvirus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Attempts to protect rabbits against challenge with virulent, cell-associated, malignant catarrhal fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

The immune response to Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Herpesvirus entry: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Induction of immune responses by DNA vaccines in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Immunization of livestock with DNA vaccines: current studies and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Cloning of herpesviral genomes as bacterial artificial chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

Characteristics of live bovine herpesvirus-1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.133

21 January 2018

Identifiers

DOI

10.1586/14760584.5.1.133

1 reference

13 August 2017

1 reference